M&A / Deals URA and Lilly join forces to harmonise drug-wearable obesity care Pharmaceutical TechnologyLilly and URA's partnership marks another high-profile collaboration between the consumer health and life science sectors.Metabolic & GLP-1Read full story pharminent June 24, 2026 (Last updated: June 26, 2026) Pharmaceutical Technology Lilly and URA’s partnership marks another high-profile collaboration between the consumer health and life science sectors. Metabolic & GLP-1 Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Boehringer and Combotope partner for cancer antibodiesNext: Lundbeck to present new Vyepti and bocunebart data at EAN 2026 Related Stories M&A / Deals Supernus and Indivior merge to create CNS mega-company with 11 approved drugs pharminent August 3, 2026 M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026 M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026
